A question worth asking
Which effects are known, and which questions remain?
It is reasonable to ask for both parts of the answer: what has been seen, and what has not been settled.
What older reports found
Older studies and a review most often described brief redness of the face and pain where an injection was given.
What they cannot settle
Those reports were mainly about children and do not establish the long-term safety of current adult treatment.
Why the missing information sheet matters
Before a product can be approved, it undergoes review at the Food and Drug Administration (FDA) for the particular use proposed.
As of September 28, 2026, no current information sheet reviewed by the FDA covers pregnancy or the frequency of unwanted effects for sermorelin.
A label for another hormone medicine cannot fill in that gap for sermorelin.
Bring your list of medicines and past illnesses. Ask how those affect the decision, including any history of blood sugar problems, swelling from fluid, or tumors.
Mention any current pregnancy, plans for pregnancy, or breastfeeding that apply to you.
What concerns come from other hormone medicines?
In reviews of related drugs, the FDA raised concerns tied to higher growth hormone levels, including blood sugar, fluid build-up, and tumors.
These warnings came from reviews of other medicines. They do not tell us how often these problems happen with sermorelin or show that sermorelin causes cancer.
Ask what the person treating you would watch for and what would lead them to reconsider treatment.
Space for your answers
Write for your own use. Keep a copy before leaving this page.
Ask how the answer relates to your situation.
Keep the difference between a known effect and a concern.